Rapid Cardiac Markers
Rapid detection of troponin, CK-MB or myoglobin in a blood specimen can be the difference between life and death in cases of myocardial infarction. Given the widespread occurrence of heart attacks among increasingly heavy populations across developed and developing nations – this is a valuable (in every sense of the word) technology to get involved in. Find the latest and most informative reports below.
About Central Venous Access Devices
Central venous access devices are inserted into the central venous system to administer medication or fluids, draw blood, and measure central venous pressure. These...
EUR 2296USD 2,500GBP 1,690
This research service analyzes the market for cardiac biomarkers within the United States The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure...
EUR 5511USD 6,000GBP 4,057
Approximately 5 million people in the United States have heart failure, with 550,000 new cases diagnosed annually The condition is the number one cause for hospitalization among the elderly; one fifth...
EUR 89USD 97GBP 66